Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: Is therapeutic response predicted by Rome III subgroups?

Journal of Gastroenterology

Volumn 46, Issue 2, 2011, Pages 183-190

  Hsu, Yao Chun ^a   Liou, Jyh Ming ^b,e   Yang, Tzeng Huey ^c   Hsu, Wei Lun ^c   Lin, Hwai Jeng ^d   Wu, Huei Tang ^c   Lin, Jaw Town ^a,b,e   Wang, Hsiu Po ^b,e   Wu, Ming Shiang ^b,e  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c LOTUNG POH AI HOSPITAL   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Epigastric pain syndrome; Functional dyspepsia; Lansoprazole; Mosapride; Postprandial distress syndrome

Indexed keywords

LANSOPRAZOLE; MOSAPRIDE; PROKINETIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DYSPEPSIA; EPIGASTRIC PAIN; FEMALE; FUNCTIONAL DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HONG KONG INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; OPEN STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PARALLEL DESIGN; POSTPRANDIAL DISTRESS SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ABDOMINAL PAIN; ADULT; ANTI-ULCER AGENTS; BENZAMIDES; DYSPEPSIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; MULTIVARIATE ANALYSIS; PROTON PUMP INHIBITORS; REGRESSION ANALYSIS; SEROTONIN RECEPTOR AGONISTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79954442464     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0334-1     Document Type: Article

References (40)

1. J Tack NJ Talley M Camilleri G Holtmann P Hu JR Malagelada, et al. 2006 Functional gastroduodenal disorders Gastroenterology 130 5 1466 1479 10.1053/j.gastro.2005.11.059 16678560
2. NJ Talley AR Zinsmeister CD Schleck LJ Melton 3rd 1992 Dyspepsia and dyspepsia subgroups: a population-based study Gastroenterology 102 4 Pt 1 1259 1268 1:STN:280:DyaK383gtFGltg%3D%3D 1551533
3. HB El-Serag NJ Talley 2004 Systemic review: the prevalence and clinical course of functional dyspepsia Aliment Pharmacol Ther 19 6 643 654 1:STN:280:DC%2BD2c7jtVOmug%3D%3D 10.1111/j.1365-2036.2004.01897.x 15023166 (Pubitemid 38445425)
4. HB El-Serag NJ Talley 2003 Health-related quality of life in functional dyspepsia Aliment Pharmacol Ther 18 4 387 393 1:STN:280:DC%2BD3svjt1yntw%3D%3D 10.1046/j.1365-2036.2003.01706.x 12940923 (Pubitemid 37070236)
5. P Moayyedi J Mason 2002 Clinical and economic consequences of dyspepsia in the community Gut 50 Suppl 4 iv10-2 11953338
6. L Agreus L Borgquist 2002 The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden Pharmacoeconomics 20 5 347 355 10.2165/00019053-200220050-00006 11994044 (Pubitemid 34569368)
7. M Camilleri D Dubois B Coulie M Jones PJ Kahrilas AM Rentz, et al. 2005 Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study Clin Gastroenterol Hepatol 3 6 543 552 10.1016/S1542-3565(05)00153-9 15952096 (Pubitemid 40824747)
8. G Sarnelli P Caenepeel B Geypens J Janssens J Tack 2003 Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia Am J Gastroenterol 98 4 783 788 10.1111/j.1572-0241.2003.07389.x 12738456 (Pubitemid 36576302)
9. J Tack R Bisschops G Sarnelli 2004 Pathophysiology and treatment of functional dyspepsia Gastroenterology 127 4 1239 1255 10.1053/j.gastro.2004.05. 030 15481001 (Pubitemid 39345892)
10. J Tack H Piessevaux B Coulie P Caenepeel J Janssens 1998 Role of impaired gastric accommodation to a meal in functional dyspepsia Gastroenterology 115 6 1346 1352 1:STN:280:DyaK1M%2FlsFGktw%3D%3D 10.1016/S0016-5085(98)70012-5 9834261 (Pubitemid 28545984)
11. J Tack P Caenepeel B Fischler H Piessevaux J Janssens 2001 Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia Gastroenterology 121 3 526 535 1:STN:280:DC%2BD3MvnvFSntg%3D%3D 10.1053/gast.2001.27180 11522735 (Pubitemid 32822566)
12. JA Lunding OH Gilja T Hausken A Bayati H Mattsson A Berstad 2007 Distension-induced gastric accommodation in functional dyspepsia: effect of autonomic manipulation Neurogastroenterol Motil 19 5 365 375 1:STN:280:DC%2BD2s3pvVSjsA%3D%3D 10.1111/j.1365-2982.2006.00896.x 17509018 (Pubitemid 46763510)
13. HP Parkman MA Miller D Trate LC Knight JL Urbain AH Maurer, et al. 1997 Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia J Clin Gastroenterol 24 4 214 219 1:STN:280: DyaK2szps1Kkuw%3D%3D 10.1097/00004836-199706000-00006 9252843 (Pubitemid 27310589)
14. RM Zagari GR Law L Fuccio V Cennamo MS Gilthorpe D Forman, et al. 2010 Epidemiology of functional dyspepsia and subgroups in the Italian general population: an endoscopic study Gastroenterology 138 4 1302 1311 10.1053/j.gastro.2009.12.057 20074574
15. YC Hsu JM Liou SC Liao TH Yang HT Wu WL Hsu, et al. 2009 Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria Am J Gastroenterol 104 10 2534 2542 10.1038/ajg.2009.328 19532128
16. P Aro NJ Talley J Ronkainen T Storskrubb M Vieth SE Johansson, et al. 2009 Anxiety is associated with uninvestigated and functional dyspepsia (Rome III criteria) in a Swedish population-based study Gastroenterology 137 1 94 100 10.1053/j.gastro.2009.03.039 19328797
17. SJ Veldhuyzen van Zanten MJ Jones M Verlinden NJ Talley 2001 Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis Am J Gastroenterol 96 3 689 696 1:CAS:528:DC%2BD3MXivFCntrY%3D 10.1016/S0002-9270(00)02314-5 11280535 (Pubitemid 32240716)
18. P Moayyedi BC Delaney N Vakil D Forman NJ Talley 2004 The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis Gastroenterology 127 5 1329 1337 10.1053/j.gastro.2004.08.026 15521002 (Pubitemid 39457759)
19. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006(4);CD001960.
20. WH Wang JQ Huang GF Zheng HH Xia WM Wong XG Liu, et al. 2007 Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials Clin Gastroenterol Hepatol 5 2 178 185 1:CAS:528:DC%2BD2sXjtlKjsr0%3D 10.1016/j.cgh.2006.09.012 17174612 (quiz 40) (Pubitemid 46216930)
21. B Geeraerts J Tack 2008 Functional dyspepsia: past, present, and future J Gastroenterol 43 4 251 255 10.1007/s00535-008-2167-8 18458839 (Pubitemid 351650034)
22. WH Hu KF Lam YH Wong CL Lam WM Hui KC Lai, et al. 2002 The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia J Gastroenterol Hepatol 17 5 545 551 10.1046/j.1440-1746.2002.02713.x 12084027 (Pubitemid 34748175)
23. WM Wong BC Wong WK Hung YK Yee AW Yip ML Szeto, et al. 2002 Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients Gut 51 4 502 506 1:CAS:528:DC%2BD3sXhslWmtrk%3D 10.1136/gut.51.4.502 12235071
24. MB Lee YJ Lee LL Yen MH Lin BH Lue 1990 Reliability and validity of using a Brief Psychiatric Symptom Rating Scale in clinical practice J Formos Med Assoc 89 12 1081 1087 1:STN:280:DyaK3M3jtFymsQ%3D%3D 1982678
25. YC Lee HP Wang HM Chiu SC Liao SP Huang YP Lai, et al. 2006 Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy J Gastroenterol Hepatol 21 5 798 804 10.1111/j.1440-1746.2005.04034.x 16704526 (Pubitemid 43793274)
26. AJ Matheson B Jarvis 2001 Lansoprazole: an update of its place in the management of acid-related disorders Drugs 61 12 1801 1833 1:CAS:528: DC%2BD3MXot1Cnt74%3D 10.2165/00003495-200161120-00011 11693467 (Pubitemid 32982160)
27. Y Mine T Yoshikawa S Oku R Nagai N Yoshida K Hosoki 1997 Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro J Pharmacol Exp Ther 283 3 1000 1008 1:CAS:528:DyaK1cXis1Ciug%3D%3D 9399969 (Pubitemid 28016469)
28. Y Kinoshita T Hashimoto A Kawamura M Yuki K Amano H Sato, et al. 2005 Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia Aliment Pharmacol Ther 21 Suppl 2 37 41 1:CAS:528:DC%2BD2MXlvFShtb0%3D 10.1111/j.1365-2036.2005.02472.x 15943845 (Pubitemid 40806579)
29. M Otaka M Jin M Odashima T Matsuhashi I Wada Y Horikawa, et al. 2005 New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline Aliment Pharmacol Ther 21 Suppl 2 42 46 1:CAS:528: DC%2BD2MXlvFShtbo%3D 10.1111/j.1365-2036.2005.02473.x 15943846 (Pubitemid 40806580)
30. BI Hallerback G Bommelaer E Bredberg M Campbell M Hellblom K Lauritsen, et al. 2002 Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study Aliment Pharmacol Ther 16 5 959 967 1:CAS:528:DC%2BD38Xkt1Gktr4%3D 10.1046/j.1365-2036.2002.01236.x 11966505 (Pubitemid 34461766)
31. T Hiyama M Yoshihara K Matsuo H Kusunoki T Kamada M Ito, et al. 2007 Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia J Gastroenterol Hepatol 22 3 304 310 1:CAS:528:DC%2BD2sXksFKnsbo%3D 10.1111/j.1440-1746.2006.04493.x 17295758 (Pubitemid 46238756)
32. RJ Laheij RW De Koning AM Horrevorts RJ Rongen LG Rossum EM Witteman, et al. 2004 Predominant symptom behavior in patients with persistent dyspepsia during treatment J Clin Gastroenterol 38 6 490 495 10.1097/01.mcg.0000123164. 86324.24 15220683 (Pubitemid 38808421)
33. KA Gwee JE Hwang KY Ho KG Yeoh CF Lum PK Ang 2008 In-practice predictors of response to proton pump inhibitor therapy in primary care patients with dyspepsia in an Asian population J Clin Gastroenterol 42 2 134 138 1:CAS:528:DC%2BD1cXosFChuw%3D%3D 10.1097/01.mcg.0000225620.02094.c3 18209580
34. G Holtmann NJ Talley T Liebregts B Adam C Parow 2006 A placebo-controlled trial of itopride in functional dyspepsia N Engl J Med 354 8 832 840 1:CAS:528:DC%2BD28Xhsl2gs7Y%3D 10.1056/NEJMoa052639 16495395 (Pubitemid 43290921)
35. NJ Talley V Meineche-Schmidt P Pare M Duckworth P Raisanen A Pap, et al. 1998 Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies) Aliment Pharmacol Ther 12 11 1055 1065 1:CAS:528:DyaK1cXotVeruro%3D 10.1046/j.1365-2036.1998.00410.x 9845395 (Pubitemid 28508719)
36. SV van Zanten D Armstrong N Chiba N Flook RJ White B Chakraborty, et al. 2006 Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial Am J Gastroenterol 101 9 2096 2106 10.1111/j.1572-0241.2006.00751.x 16817845 (Pubitemid 44337636)
37. NJ Talley GR Locke BD Lahr AR Zinsmeister M Cohard-Radice TV D'Elia, et al. 2006 Predictors of the placebo response in functional dyspepsia Aliment Pharmacol Ther 23 7 923 936 1:STN:280:DC%2BD287nvFKktQ%3D%3D 10.1111/j.1365-2036.2006.02845.x 16573795
38. EJ Irvine WE Whitehead WD Chey K Matsueda M Shaw NJ Talley, et al. 2006 Design of treatment trials for functional gastrointestinal disorders Gastroenterology 130 5 1538 1551 10.1053/j.gastro.2005.11.058 16678567
39. J Danesh M Lawrence M Murphy S Roberts R Collins 2000 Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia Arch Intern Med 160 8 1192 1198 1:STN:280: DC%2BD3c3kvVCktA%3D%3D 10.1001/archinte.160.8.1192 10789614 (Pubitemid 30227031)
40. K Adachi T Katsube A Kawamura T Takashima M Yuki K Amano, et al. 2000 CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole Aliment Pharmacol Ther 14 10 1259 1266 1:CAS:528: DC%2BD3cXotV2jsb0%3D 10.1046/j.1365-2036.2000.00840.x 11012469